| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0057 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |